Journal of Pharmacovigilance

Cecilia Fernández de Valle-Laisequilla

Publications

• Research Article
  Adverse Events Reactions Reported With the Use of a Fixed-Dose Combination of Nor-Pseudoephedrine, Triiodothyronine, Atropine, Aloin and Diazepam in Obese Mexican Patients
  Author(s): Cinthya Galicia-Quintanar, Cecilia Fernández de Valle-Laisequilla, Herman Soto-Molina, Eleazar Lara-Padilla, Juan Carlos Huerta-Cruz and Juan Gerardo Reyes-García Cinthya Galicia-Quintanar, Cecilia Fernández de Valle-Laisequilla, Herman Soto-Molina, Eleazar Lara-Padilla, Juan Carlos Huerta-Cruz and Juan Gerardo Reyes-García
  
  Background: Obesity is a health problem worldwide. Although the first-line intervention is implementing a comprehensive program of diet, exercise and behavior changes, some patients require additional drug treatment. Among the medications used wide and effectively for obesity in Mexico is found a combination consisting of 5 active ingredients: nor-pseudoephedrine, triiodothyronine, atropine, aloin and diazepam (Redotex®), whose rationality and safety remains controversial. Objective: To analyze the adverse event reports received in the pharmacovigilance unit of the manufacturer company, from 2009 to 2014, in order to assess the existence of related potential safety issues. Method: Adverse events were sorted by frequency and classified by intensity and causality. The groups mainly affected by ad.. View More»
  DOI: 10.4172/2329-6887.1000185

  Abstract PDF